Metabolic syndrome components and age-related cataract: The Singapore Malay Eye Study

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 5, 2011, Pages 2397-2404

  Sabanayagam, Charumathi ^a,b   Wang, Jie Jin ^c,d   Mitchell, Paul ^c   Tan, Ava Grace ^c   Tai, E Shyong ^b   Aung, Tin ^b   Saw, Seang Mei ^b   Wong, Tien Yin ^b,d  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN;

ADULT; AGE RELATED CATARACT; AGED; ARTICLE; BODY MASS; CATARACT; CORTICAL CATARACT; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUCLEAR CATARACT; OBESITY; POSTERIOR SUBCAPSULAR CATARACT; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGAPORE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; AGING; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CATARACT; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; SINGAPORE; TRIGLYCERIDES;

EID: 79956024612     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6373     Document Type: Article

References (51)

1. Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA. 2003;290:2057-2060.
2. Wong TY, Loon SC, Saw SM. The epidemiology of age related eye diseases in Asia. Br J Ophthalmol. 2006;90:506-511.
3. Klein BE, Klein R, Lee KE. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol. 1998;126:782-790.
4. Saxena S, Mitchell P, Rochtchina E. Five-year incidence of cataract in older persons with diabetes and pre-diabetes. Ophthalmic Epidemiol. 2004;11:271-277.
5. Rowe NG, Mitchell PG, Cumming RG, Wans JJ. Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol. 2000;7:103-114.
6. Hennis A, Wu SY, Nemesure B, Leske MC. Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. Arch Ophthalmol. 2004;122:525-530.
7. Weintraub JM, Willett WC, Rosner B, Colditz GA, Seddon JM, Hankinson SE. A prospective study of the relationship between body mass index and cataract extraction among US women and men. Int J Obes Relat Metab Disord. 2002;26:1588-1595.
8. Schaumberg DA, Glynn RJ, Christen WG, Hankinson SE, Hennekens CH. Relations of body fat distribution and height with cataract in men. Am J Clin Nutr. 2000;72:1495-1502.
9. Jacques PF, Moeller SM, Hankinson SE, et al. Weight status, abdominal adiposity, diabetes, and early age-related lens opacities. Am J Clin Nutr. 2003;78:400-405.
10. Schaumberg DA, Glynn RJ, Christen WG, Ajani UA, Sturmer T, Hennekens CH. A prospective study of blood pressure and risk of cataract in men. Ann Epidemiol. 2001;11:104-110.
11. Younan C, Mitchell P, Cumming R, Rochtchina E, Panchapakesan J, Tumuluri K. Cardiovascular disease, vascular risk factors and the incidence of cataract and cataract surgery: the Blue Mountains Eye Study. Ophthalmic Epidemiol. 2003;10:227-240.
12. Hiller R, Sperduto RD, Reed GF, D'Agostino RB, Wilson PW. Serum lipids and age-related lens opacities: a longitudinal investigation: the Framingham Studies. Ophthalmology. 2003;110:578-583.
13. Klein BE, Klein R, Lee KE. Cardiovascular disease, selected cardiovascular disease risk factors, and age-related cataracts: the Beaver Dam Eye Study. Am J Ophthalmol. 1997;123:338-346.
14. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet. 2005;366:1059-1062.
15. Nichols GA, Moler EJ. Diabetes incidence for all possible combinations of metabolic syndrome components. Diabetes Res Clin Pract. 2010;90:115-121.
16. Tan GS, Wong TY, Fong CW, Aung T. Diabetes, metabolic abnormalities, and glaucoma. Arch Ophthalmol. 2009;127:1354-1361.
17. Costa LA, Canani LH, Lisboa HR, Tres GS, Gross JL. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in type 2 diabetes. Diabet Med. 2004;21:252-255.
18. Kawasaki R, Tielsch JM, Wang JJ, et al. The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata study. Br J Ophthalmol. 2008;92:161-166.
19. Wong TY, Duncan BB, Golden SH, et al. Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study. Invest Ophthalmol Vis Sci. 2004;45:2949-2954.
20. Tan JS, Wang JJ, Mitchell P. Influence of diabetes and cardiovascular disease on the long-term incidence of cataract: the Blue Mountains eye study. Ophthalmic Epidemiol. 2008;15:317-327.
21. Lindblad BE, Hakansson N, Philipson B, Wolk A. Metabolic syndrome components in relation to risk of cataract extraction: a prospective cohort study of women. Ophthalmology. 2008;115: 1687-1692.
22. Paunksnis A, Bojarskiene F, Cimbalas A, Cerniauskiene LR, Luksiene DI, Tamosiunas A. Relation between cataract and metabolic syndrome and its components. Eur J Ophthalmol. 2007;17:605-614.
23. Galeone C, Petracci E, Pelucchi C, Zucchetto A, La VC, Tavani A. Metabolic syndrome, its components and risk of age-related cataract extraction: a case-control study in Italy. Ann Epidemiol. 2010; 20:380-384.
24. Cockram CS. The epidemiology of diabetes mellitus in the Asia-Pacific region. Hong Kong Med J. 2000;6:43-52.
25. Foong AW, Saw SM, Loo JL, et al. Rationale and methodology for a population-based study of eye diseases in Malay people: the Singapore Malay Eye Study (SiMES). Ophthalmic Epidemiol. 2007;14: 25-35.
26. Wong TY, Chong EW, Wong WL, et al. Prevalence and causes of low vision and blindness in an urban Malay population: the Singapore Malay Eye Study. Arch Ophthalmol. 2008;126:1091-1099.
27. Boey PY, Tay WT, Lamoureux EL, et al. C-reactive protein and age-related macular degeneration and cataract: the Singapore Malay Eye Study. Invest Ophthalmol Vis Sci. 2010;51:1880-1885.
28. Mitchell P, Cumming RG, Attebo K, Panchapakesan J. Prevalence of cataract in Australia: the Blue Mountains eye study. Ophthalmology. 1997;104:581-588.
29. Klein BE, Klein R, Linton KL, Magli YL, Neider MW. Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmology. 1990;97:1428-1433.
30. Seah SK, Wong TY, Foster PJ, Ng TP, Johnson GJ. Prevalence of lens opacity in Chinese residents of Singapore: the Tanjong Pagar survey. Ophthalmology. 2002;109:2058-2064.
31. Lim LS, Tai ES, Aung T, et al. Relation of age-related cataract with obesity and obesity genes in an Asian population. Am J Epidemiol. 2009;169:1267-1274.
32. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
33. WHD expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163.
34. American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care. 2007;30:S4-41.
35. Allison PD. Logistic regression using the SAS system: theory and application. Cary, NC: SAS Institute; 1999.
36. Hiller R, Sperduto RD, Ederer F. Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol. 1986;124:916-925.
37. Stitt AW. Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol. 2001; 85:746-753.
38. Kador PF, Kinoshita JH. Diabetic and galactosaemic cataracts. CIBA Found Symp. 1984;106:110-131.
39. Kanthan GL, Wang JJ, Rochtchina E, Mitchell P. Use of antihypertensive medications and topical beta-blockers and the long-term incidence of cataract and cataract surgery. Br J Ophthalmol. 2009; 93:1210-1214.
40. Klein BE, Klein R, Lee KE, Knudtson MD, Tsai MY. Markers of inflammation, vascular endothelial dysfunction, and age-related cataract. Am J Ophthalmol. 2006;141:116-122.
41. Weber T. Low-grade systemic inflammation, arterial structure and function, and hypertension. Am J Hypertens. 2010;23:346.
42. Meyer D, Parkin D, Maritz FJ, Liebenberg PH. Abnormal serum lipoprotein levels as a risk factor for the development of human lenticular opacities. Cardiovasc J S Afr. 2003;14:60-64.
43. Tsutsumi K, Inoue Y, Yoshida C. Acceleration of development of diabetic cataract by hyperlipidemia and low high-density lipoprotein in rats. Biol Pharm Bull. 1999;22:37-41.
44. Klimov AN, Gurevich VS, Nikiforova AA, et al. Antioxidative activity of high density lipoproteins in vivo. Atherosclerosis. 1993;100:13-18.
45. Varma SD, Chand D, Sharma YR, Kuck JF Jr, Richards RD. Oxidative stress on lens and cataract formation: role of light and oxygen. Curr Eye Res. 1984;3:35-57.
46. von EA, Hersberger M, Rohrer L. Current understanding of the metabolism and biological actions of HDL. Curr Opin Clin Nutr Metab Care. 2005;8:147-152.
47. Cheung N, Wong TY. Obesity and eye diseases. Surv Ophthalmol. 2007;52:180-195.
48. Kuang TM, Tsai SY, Hsu WM, Cheng CY, Liu JH, Chou P. Body mass index and age-related cataract: the Shihpai Eye Study. Arch Ophthalmol. 2005;123:1109-1114.
49. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-1428.
50. Schaumberg DA, Ridker PM, Glynn RJ, Christen WG, Dana MR, Hennekens CH. High levels of plasma C-reactive protein and future risk of age-related cataract. Ann Epidemiol. 1999;9:166-171.
51. Frohlich M, Imhof A, Berg G, et al. Association between C-reactive protein and features of the metabolic syndrome: a populationbased study. Diabetes Care. 2000;23:1835-1839.